Gastrointestinal Disorders
Innovative research focusing on celiac disease treatment, evaluating a novel therapeutic agent KAN-101 for its effectiveness in protecting against gluten-induced intestinal changes.
- Celiac Disease Management
- Intestinal Mucosa Protection
- Gluten Challenge Response
The trials aim to measure changes in intestinal tissue structure and assess therapeutic tolerance.
Inflammatory Bowel Disease
Comprehensive studies on ulcerative colitis examining the novel compound obefazimod, with both short-term and long-term evaluation protocols for efficacy and safety.
- Endoscopic Improvement
- Symptomatic Remission
- Long-term Safety Assessment
Research focuses on moderate to severe cases with extended follow-up periods.
Advanced Digestive Disease Research
Groundbreaking research into Crohn’s Disease treatment, investigating targeted therapies for adult patients with moderate to severe symptoms.
- Therapeutic Efficacy
- Safety Profiling
- Mechanistic Assessment
The studies aim to advance personalized treatment approaches for inflammatory bowel conditions.
